Antioxidants and Restenosis — Human Studies
- 1 January 2000
- book chapter
- Published by Springer Nature
Abstract
No abstract availableKeywords
This publication has 65 references indexed in Scilit:
- Lovastatin plus probucol for prevention of restenosis after percutaneous transluminal coronary angioplastyThe American Journal of Cardiology, 1996
- Effectiveness of Probucol in Preventing Restenosis after Percutaneous Transluminal Coronary Angioplasty.Japanese Heart Journal, 1996
- Inhibition of Hypercholesterolemia-Induced Atherosclerosis in the Nonhuman Primate by ProbucolArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Lowering of HDL 2b by Probucol Partly Explains the Failure of the Drug to Affect Femoral Atherosclerosis in Subjects With HypercholesterolemiaArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Combination of Vitamins C and E Alters the Response to Coronary Balloon Injury in the PigArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- The effect of probucol on femoral atherosclerosis: The Probucol Quantitative Regression Swedish Trial (PQRST)The American Journal of Cardiology, 1994
- Low-dose alpha-tocopherol improves and high-dose alpha-tocopherol worsens endothelial vasodilator function in cholesterol-fed rabbits.Journal of Clinical Investigation, 1994
- Definition and measurement of restenosis after successful coronary angioplasty: Implications for clinical trialsAmerican Heart Journal, 1993
- ProbucolDrugs, 1989
- Book ReviewAmbulatory Pediatric CareNew England Journal of Medicine, 1989